Medical News

RSS

Plymouth becomes active research partner with Brain Tumour Research

Plymouth University Peninsula Schools of Medicine and Dentistry will now become an active research and fundraising partner with Brain Tumour Research. The charity will support research and supply dedicated members of staff with expertise in fundraising, marketing and PR to work at both local and national levels alongside existing teams, creating a dynamic fundraising programme.

5 Mar 2014

Researchers unlock controversial structure in heart cells

Brandeis University researchers have unlocked a controversial structure in heart cells responsible for regulating heart contractions.

5 Mar 2014

Stem cells from patients offer model, drug-discovery platform for early-onset form of Alzheimer's

Harvard stem cell scientists have successfully converted skins cells from patients with early-onset Alzheimer's into the types of neurons that are affected by the disease, making it possible for the first time to study this leading form of dementia in living human cells. This may also make it possible to develop therapies far more quickly and accurately than before.

5 Mar 2014

Taiwanese teenagers who become sexually active at young age are more likely to be aggressive

Taiwanese teenagers - and especially females - who become sexually active at a very young age are more likely to be rule-breakers and be more aggressive than their peers. These are the findings of a national study of Taiwanese youth led by Wei J. Chen of the National Taiwan University, with Chia-Hua Chan as first author.

5 Mar 2014

3.5 million estimated Medicaid signups under health law

Avalere Health projects that of the 8.9 million people "determined eligible" for Medicaid starting last Oct. 1, the number of new enrollees under the health law is likely much smaller -- between 2.4 million and 3.5 million. Other reports look at how health insurance could result in nearly half a million more Americans getting tested for HIV by 2017 -- but how 60,000 people with the virus will be left uninsured in states not expanding Medicaid.

5 Mar 2014

Overweight Group Health patients with hypertension benefit from 'pocket dietitian'

A rich chocolate cake is tempting you, but where is a dietitian when you need one? The e-Care for Heart Wellness study sought to solve this problem. In the study, Group Health patients who were overweight and had hypertension were more likely to have lost 10 pounds in six months if they had secure online access to a dietitian than if they received only information and usual care. The American Journal of Preventive Medicine published the e-Care study.

4 Mar 2014

Experimental drug nivolumab shrinks tumors in patients with advanced melanoma

An experimental drug aimed at restoring the immune system's ability to spot and attack cancer halted cancer progression or shrank tumors in patients with advanced melanoma, according to a multisite, early-phase clinical trial at Johns Hopkins Kimmel Cancer Center and 11 other institutions. All patients had experienced disease progression despite prior systemic therapies, and most had received two or more prior treatments.

4 Mar 2014

Bruker opens new preclinical imaging center of excellence for the Americas

Bruker (NASDAQ: BRKR) today announced the official opening of a new Preclinical Imaging Center of Excellence for the Americas in Billerica, Massachusetts. The facility offers advanced development, demonstration and support facilities for Bruker’s industry-leading portfolio of preclinical imaging instrumentation and multimodal platforms.

4 Mar 2014

New minispec sample automation system for TD-NMR applications delivers increased productivity and efficiency

At Pittcon 2014 Bruker announced a new sample automation system for the minispec mq and mq-one series, a new easy to use and cost-effective system that brings sample automation to routine Time-Domain (TD)-NMR applications. Its fast sample exchange of 10mm OD sample tubes delivers new levels of maximum throughput and thanks to automated and precise tempering times measurement reliability is improved, significantly boosting productivity of the minispec series.

4 Mar 2014

Bruker announces next generation JuiceScreener™ 3.0

At Pittcon 2014, Bruker today announced the third release of its successful NMR JuiceScreenerTM. The new release comes with significant enhancements that enable the accurate, swift, automated screening of even more fruit juice types from just a single experiment.

4 Mar 2014

Bruker announces successful installation of World’s First compact 900 MHz actively refrigerated magnet for NMR spectroscopy at UCSD

Bruker today announced the successful installation of an Ascend™ Aeon 900 magnet, the world’s first compact, single-story NMR magnet with active refrigeration at the University of California, San Diego (UCSD) in La Jolla, CA.

4 Mar 2014

More support for interhemispheric disconnectivity in bipolar disorder

A UK study supports a role for interhemispheric disconnectivity in bipolar disorder, showing reduced corpus callosum area and thickness in patients with the condition.

4 Mar 2014

Cancer contributes to schizophrenia mortality

Study findings confirm the increased risk of death from physical diseases among patients with schizophrenia, and reveal cancer mortality as an issue among middle-aged patients.

4 Mar 2014

Lucideon now provides wear testing and debris analysis for orthopaedic implant manufacturers across Europe and the US

Lucideon, the international provider of materials development, testing and assurance, and formerly known as Ceram and M+P Labs, has added wear testing and debris analysis to its services for orthopaedic implant manufacturers across Europe and the US.

From Lucideon 4 Mar 2014

Beckman Coulter Life Sciences announces agreement with Wyatt Technology Corporation

Beckman Coulter Life Sciences today announced an agreement with Wyatt Technology Corporation enabling collaboration on products, applications and technical development. The partnership brings together Wyatt’s expertise in protein characterization, light scattering and biophysics with Beckman Coulter’s expertise in particle counting, particle characterization and cell viability measurement.

4 Mar 2014

Neos Therapeutics completes private financing round, raises $15.5M

Neos Therapeutics, Inc. ("Neos" or "the Company"), a highly differentiated oral drug delivery company with an exciting portfolio of proprietary technologies and a late-stage pipeline of innovative controlled release (CR) products for ADHD, announced today that it has completed an oversubscribed round of private financing, raising a total of $15.5 million.

4 Mar 2014

AAA gets orphan drug designation status for radiopharmaceutical, Gallium-68 DOTATATE

Advanced Accelerator Applications (AAA), a fast growing international player in Molecular Nuclear Medicine (MNM), announced today that they have received orphan drug designation status for their radiopharmaceutical, Gallium-68 DOTATATE.

4 Mar 2014

Ziehm Imaging honored as Best Company for Innovation & Leadership at the IAIR GLOBAL AWARDS

Ziehm Imaging is announced to be the winner in the category "Best Company for Innovation & Leadership" at this year's IAIR GLOBAL AWARDS. More than 500 attendees were present at the award dinner held at the Sheraton Tower in Hong Kong last Friday.

4 Mar 2014

Omeros submits investigational new drug to initiate OMS721 Phase 2 clinical program

Omeros Corporation today announced that it has submitted to the U.S. Food and Drug Administration (FDA) an investigational new drug (IND) application to initiate the Phase 2 clinical program for OMS721, the company's lead human monoclonal antibody targeting mannan-binding lectin‑associated serine protease-2 (MASP-2), the key regulator of the lectin pathway of the immune system.

4 Mar 2014

GTx provides clinical updates, reports financial results for fourth quarter and full year 2013

GTx, Inc. today provided a Company update and reported financial results for the fourth quarter and full year 2013.

4 Mar 2014

Medical News

Plymouth becomes active research partner with Brain Tumour Research

Researchers unlock controversial structure in heart cells

Stem cells from patients offer model, drug-discovery platform for early-onset form of Alzheimer's

Taiwanese teenagers who become sexually active at young age are more likely to be aggressive

3.5 million estimated Medicaid signups under health law

Overweight Group Health patients with hypertension benefit from 'pocket dietitian'

Experimental drug nivolumab shrinks tumors in patients with advanced melanoma

Bruker opens new preclinical imaging center of excellence for the Americas

New minispec sample automation system for TD-NMR applications delivers increased productivity and efficiency

Bruker announces next generation JuiceScreener™ 3.0

Bruker announces successful installation of World’s First compact 900 MHz actively refrigerated magnet for NMR spectroscopy at UCSD

More support for interhemispheric disconnectivity in bipolar disorder

Cancer contributes to schizophrenia mortality

Lucideon now provides wear testing and debris analysis for orthopaedic implant manufacturers across Europe and the US

Beckman Coulter Life Sciences announces agreement with Wyatt Technology Corporation

Neos Therapeutics completes private financing round, raises $15.5M

AAA gets orphan drug designation status for radiopharmaceutical, Gallium-68 DOTATATE

Ziehm Imaging honored as Best Company for Innovation & Leadership at the IAIR GLOBAL AWARDS

Omeros submits investigational new drug to initiate OMS721 Phase 2 clinical program

GTx provides clinical updates, reports financial results for fourth quarter and full year 2013

Directed enzyme evolution and the Nobel Prize: Making enzymes evolve in the lab

Advancing Motor Neuron Disease Diagnosis with Non-Invasive Ultrasound and AI

How agentic AI is reshaping laboratory workflows

Latest News